SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

SEMENIUK, Guillermo. Células madre: Vida más allá de la muerte. Medicina (B. Aires) [online]. 2012, vol.72, n.5, pp. 443-444. ISSN 0025-7680.

    1. Latil M, Rocheteau P, Châtre L, et al. Skeletal muscle stem cells adopt a dormant cell state postmortem and retain regenerative capacity. Nat Commun 2012; Jun 12; 3: 903. En: http://www.nature.com/ncomms/journal/v3/n6/pdf/ncomms1890.pdf; consultado 3/8/12; Press release, I. Pasteur. En: http://www.pasteur.fr/ip/easysite/pasteur/en/press/press-releases/2012/postmortem-stem-cells; consultado 20/8/12. [ Links ]

    2. Vogel G. Cancer Stem Cells Can Fuel Tumor Growth. En: http://www.wired.com/wiredscience/2012/08/cancer-stemcells/; consultado 3/8/12. [ Links ]

    3. Schepers A G, Snippert H J, Stange D E, et al. Lineage Tracing Reveal Lgr5+ Stem Cell Activity in Mouse Intestinal Adenoma. Science, 2012; 337: 730-5. [ Links ]

    4. Zhenyu Tang, Aijun Wang, Falei Yuan, et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nature Communications, June 2012. En: http://www.nature.com/ncomms/journal/v3/n6/full/ncomms1867.html; consultado 3/8/12. [ Links ]

    5. Semeniuk GB. Stem cells en relación a la reparación de lesiones pulmonares. Revista Argentina de Medicina Respiratoria 2005; 1: 1-2. [ Links ]

    6. Pasqualini CD. Reprogramación de fibroblastos humanos a células madre. Nuevo paradigma en medicina regenerativa. Medicina (B Aires) 2008; 68: 181-3. [ Links ]

    7. Pasqualini CD. La guerra contra el cáncer. Medicina (B Aires) 2011; 71: 496-9. [ Links ]

    1. Allison, RS. Disseminated sclerosis in North Wales: an inquiry into its incidence, frequency, distribution and other etiological factors. Brain 1931; 53: 391-430. [ Links ]

    2. Poser, CM. An Atlas of Multiple Sclerosis; In: Multiple sclerosis: epidemiology. 2nd ed. Nashville: Parthenon Publishing Group 1998, p 23-35. [ Links ]

    3. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002; 104: 182-91. [ Links ]

    4. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-39. [ Links ]

    5. Rosati G, Aiello I, Pirastru MI, et al. Epidemiology of multiple sclerosis in Northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 1996; 15: 10-9. [ Links ]

    6. Cristiano E, Patrucco L, Rojas JI. A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol 2008; 15: 1273-8. [ Links ]

    7. Rosati G. Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994; 36 Suppl 2: S164-74. [ Links ]

    8. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12. [ Links ]

    9. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097. [ Links ]

    10. Cristiano E, Patrucco L, Rojas JI, et al. Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method. Eur J Neurol 2009; 16:183-7. [ Links ]

    11. Cristiano E, Patrucco L, Giunta D, Videla G, Soriano ER, Rojas JI. Incidence of multiple sclerosis in Buenos Aires: a 16-year health maintenance organization-based study. Eur J Neurol 2010; 17: 479-82. [ Links ]

    12. Melcon MO, Vergara RH, Ceratto R. Prevalencia de Esclerosis Múltiple en Junín, Provincia de Buenos Aires, Argentina. Rev Neurol 1994; 19: 3-8. [ Links ]

    13. Melcon M, Gold L, Carra A, et al. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult Scler 2008; 14: 656-62. [ Links ]

    14. Cristiano E, Patrucco L, Garcea O, et al. Prevalence of multiple sclerosis in Argentina estimated by capture recapture method. J Neurol Sci 1999; 2: A438. [ Links ]

    15. Piedrabuena R, Giobellina R, Alvarez D, V A. High prevalence of multiple sclerosis in the city of Oliva, Cordoba, Argentina. Arq Neuropsiquiatr 2004; 62: 13. [ Links ]

    16. Cristiano E, Patrucco L, Carrá A, et al. Características clínico evolutivas de la esclerosis múltiple en Argentina. Estudio multicéntrico. Neurologia Argentina 1999; 24: 13. [ Links ]

    17. Sandoval G, Fernández Liguori N, Cáceres F, Sica R, Garcea O. Características de inicio en la esclerosis múltiple en recaídas y remisiones. Neurologia Argentina 2000; 25: 36. [ Links ]

    18. Sandoval G, Villa A, Vanotti S, Garcea M, Garcea O. Esclerosis Múltiple dos décadas de experiencia. Neurología Argentina 2004; 29: 16. [ Links ]

    19. Saladino L, Fernández Liguori N. Características clínico demográficas de una población con esclerosis múltiple en un Hospital público de Capital Federal. Neurología Argentina 2006; 31: 46. [ Links ]

    20. Rojas JI, Patrucco L, Riccio P, Cristiano E. Historia natural de la esclerosis múltiple: severidad de la enfermedad en una cohorte de Argentina. Neurologia Argentina 2008; 33: 7. [ Links ]

    21. Rojas JI, Patrucco L, Cristiano E. Historia natural de la esclerois múltiple primaria progresiva en Buenos Aires. Neurologia Argentina 2009; 1: 15. [ Links ]

    22. Vetere S, Muñiz R, Luisi AM, E. Esclerosis múltiple: análisis epidemiológico. Revista Neurológica 1998; 23: 3. [ Links ]

    23. Bardeci C, Cristiano E, Torres D, Serra P. Esclerosis múltiple: Datos epidemiológicos en 150 pacientes. Revista Neurológica Argentina 1994; 19:26. [ Links ]

    24. Caceres FS, Kremenchutzky MFL, Garcea O. Análisis de una población de pacientes con esclerosis múltiple. Revista Neurológica Argentina 1993; 21: 175. [ Links ]

    25. Bardeci C, Patrucco L, Torres D, Cristiano E. Consultorio de esclerosis múltiple, cinco años de experiencia. Revista Neurológica Argentina 1993; 21: 215. [ Links ]

    26. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-78. [ Links ]

    27. Lauer K. Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies. Acta Neurol Scand Suppl 1995;161: 77-88. [ Links ]

    28. Dolinoy DC, Jirtle RL. Environmental epigenomics in human health and disease. Environ Mol Mutagen 2008; 49: 4-8. [ Links ]

    29. Kurtzke JF. MS epidemiology world wide. One view of current status. Acta Neurol Scand Suppl 1995; 161: 23-33. [ Links ]

    30. Kurtzke JF. Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis. Neurol Sci 2000; 21: 383-403. [ Links ]

    31. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5: 932-6. [ Links ]

    32. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 2006; 129: 584-94. [ Links ]

    33. Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995; 13:119-46. [ Links ]

    1. Borrell Bentz R. La educación médica de posgrado en Argentina: el desafío de una nueva práctica educativa. 1 ed. Buenos Aires: OPS/OMS, 2005. [ Links ]

    2. Barousse AP. Certificación de profesionales médicos en la especialidad Clínica Médica. Medicina (B Aires) 2002; 62: 609-11. [ Links ]

    3. Accreditation Council for Graduate Medical Education ACGME Program Requirements for Residency Education in Internal Medicine http://www.acgme.org/acWebsite/downloads/RRC_progReq/140_im_07012007.pdf.; consultado julio 2007. [ Links ]

    4. Levine RB, Hebert RS, Wright SM. Resident research and scholarly activity in internal medicine residency training programs. J Gen Intern Med 2005; 20: 155-9. [ Links ]

    5. García GMG. Residencias del equipo de salud. Sistema Nacional de Acreditación de Residencias del Equipo de Salud. Criterios básicos. Integrantes del sistema. Registros, Min. Salud y Medio Ambiente. Dirección Nacional del Boletín Oficial: Buenos Aires, 2006. [ Links ]

    6. Elizondo CM, Giunta DH, González Bernaldo de Quirós F, et al. Residencias de medicina interna en Argentina, 2008. Medicina (B Aires) 2010; 70: 143-50. [ Links ]

    7. Van der Steen JT, Ooms ME, Ader HJ, Ribbe MW, van der Wal G. Withholding antibiotic treatment in pneumonia patients with dementia: a quantitative observational study. Arch Intern Med 2002; 162: 1753-60. [ Links ]

    8. Meyers FJ, Weinberger SE, Fitzgibbons JP, et al. Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force. Acad Med 2007; 82: 1211-9. [ Links ]

    9. Fletcher KE, Underwood W 3rd, Davis SQ, et al. Effects of work hour reduction on residents' lives: a systematic review. JAMA, 2005; 294: 1088-100. [ Links ]

    10. Hamann KL, Fancher TL, aint S, Henderson MC. Clinical research during internal medicine residency: a practical guide. Am J Med 2006; 119: 277-83. [ Links ]

    11. Alguire PC, Anderson WA, Albrecht RR, Poland GA. Resident research in internal medicine training programs. Ann Intern Med 1996; 124: 321-8. [ Links ]

    12. Vinci RJ, Bauchner H, Finkelstein J, et al. Research during pediatric residency training: outcome of a senior resident block rotation. Pediatrics 2009; 124: 1126-34. [ Links ]

    13. Kanna B, Deng C, Erickson SN, et al. The research rotation: competency-based structured and novel approach to research training of internal medicine residents. BMC Med Educ 2006; 6: 52. [ Links ]

    14. Rivera JA Levine RB, Wright SM. Completing a scholarly project during residency training. Perspectives of residents who have been successful. J Gen Intern Med 2005; 20: 366-9. [ Links ]

    15. Fuentes NA, Giunta DH, Pazo V, et al. Proyecto institucional para la educación médica continua en investigación clinica. Medicina (B Aires) 2010; 70: 240-6. [ Links ]

    16. Pereiro ND, Elizondo C, Giunta D, Figa S. Clinical Eepidemiologic Research in Internal Medicine Residencies in Argentina. Qualitative Study, in 29Th World Congress of Internal Medicine 2008: Buenos Aires. [ Links ]

    17. González García GM. Residencias del equipo de salud. Sistema Nacional de Acreditación de Residencias del Equipo de Salud. Criterios básicos. Integrantes del sistema. Registros. En: http://www.femeba.org.ar/fundacion/, Min. Salud y M. Ambiente, Dirección Nacional del Boletín Oficial: Buenos Aires, 2006. [ Links ]

    1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907. [ Links ]

    2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90: 1-636. [ Links ]

    3. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27. [ Links ]

    4. Bruni L, Díaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 1789-99. [ Links ]

    5. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-5. [ Links ]

    6. Arrossi S, Ramos S, Paolino M, Sankaranarayanan R. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina. Reprod Health Matters 2008; 16: 50-8. [ Links ]

    7. Arrossi S. Proyecto para el mejoramiento del Programa Nacional de Prevención de Cáncer de Cuello Uterino en Argentina. Informe final: Diagnóstico de situación del Programa Nacional y Programas Provinciales. 1 ed. Buenos Aires: Organización Panamericana de la Salud, OPS; 2008. In: http://www.msal.gov.ar/cancer-cervico-uterino/pdf/info-equipos-salud/Diagnostico_Pub64_OPS.pdf (last accessed 14-11-2011). [ Links ]

    8. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077-85. [ Links ]

    9. Manos MM, Ting Y, Wright DK, Lewis AJ, Brocker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989; 7: 209-14. [ Links ]

    10. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76 (Pt 4): 1057-62. [ Links ]

    11. Ho L, Chan SY, Burk RD, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993; 67: 6413-23. [ Links ]

    12. Picconi MA, Gronda J, Alonio LV, et al. Human Papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants. Medicina (B Aires) 2002; 62: 209-20. [ Links ]

    13. Tonon SA, Picconi MA, Zinovich JB, et al. Human papillomavirus cervical infection in Guarani Indians from the rainforest of Misiones, Argentina. Int J Infect Dis 2004; 8: 13-9. [ Links ]

    14. Soto-De Leon S, Camargo M, Sanchez R, et al. Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One 2011; 6: e14705. [ Links ]

    15. Brito EB, Silva ID, Stávale JN, Taromaru E, Menezess RC, Martins SJ. Amerindian women of the Brazilian Amazon and STD. Eur J Gynaecol Oncol 2006; 27: 279-81. [ Links ]

    16. Kightlinger RS, Irvin WP, Archer KJ, et al. Cervical cancer and human papillomavirus in indigenous Guyanese women. Am J Obstet Gynecol 2010; 202: 626. e1-7. [ Links ]

    17. de Sanjosé S, Díaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-9. [ Links ]

    18. Parkin DM, Almonte M, Bruni L, Clifford G, Curado MP, Piñeros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine 2008; 26: L1-15. [ Links ]

    19. Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008; 26: L16-36. [ Links ]

    20. Lippman SA, Sucupira MCA, Jones HE, et al. Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 2010; 21: 105-9. [ Links ]

    21. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 2677-84. [ Links ]

    22. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008; 43: S5-25, S25. e1-41. [ Links ]

    23. Franceschi S, Rajkumar R, Snijders PJF, et al. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92: 601-6. [ Links ]

    24. Muñoz N, Méndez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004; 190: 2077-87. [ Links ]

    25. Tábora N, Bakkers JM, Quint WG, et al. Human papillomavirus infection in Honduran women with normal cytology. Cancer Causes Control 2009; 20: 1663-70. [ Links ]

    26. Spinillo A, Dal Bello B, Gardella B, Roccio M, Dacco MD, Silini EM. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Gynecol Oncol 2009; 113: 115-9. [ Links ]

    27. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006; 15: 1274-80. [ Links ]

    28. Bello BD, Spinillo A, Alberizzi P, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 2009; 81: 703-12. [ Links ]

    29. Sichero L, Ferreira S, Trottier H, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 2007; 120: 1763-8. [ Links ]

    30. Xi LF, Koutsky LA, Hildesheim A, et al. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 2007; 16: 4-10. [ Links ]

    31. Sichero L, Villa LL. Epidemiological and functional implications of molecular variants of human papillomavirus. Braz J Med Biol Res 2006; 39: 707-17. [ Links ]

    32. Tonon SA, Basiletti J, Badano I, et al. Human papillomavirus type 16 molecular variants in Guarani Indian women from Misiones, Argentina. Int J Infect Dis 2007; 11: 76-81. [ Links ]

    33. Picconi MA, Alonio LV, García Carrancá A, et al. Molecular variants of human papillomavirus (HPV) types 16 and 18 in adenocarcinomas of the cervix. Medicina (B Aires) 2000; 60: 889-94. [ Links ]

    34. Alencar TR, Cerqueira DM, da Cruz MR, Wyant PS, Ramalho ED, Martins CR. New HPV-16 European and non-European variants in Central Brazil. Virus Genes 2007; 35: 1-4. [ Links ]

    1. Ding EL, Hu FB. Smoking and type 2 diabetes: under recognized risks and disease burden. JAMA 2007; 298: 2675-6. [ Links ]

    2. Mathur RK. Role of diabetes, hypertension, and cigarette smoking on atherosclerosis. J Cardiovasc Dis Res 2010; 1: 64-8. [ Links ]

    3. Alanbaei M, Zubaid M, Al-Mallah MH, et al. Impact of diabetes and smoking epidemic in the Middle East on the presentation with acute coronary syndrome in very young patients. Angiology 2012; 63: 48-54. [ Links ]

    4. Matsubayashi H, Maeda A, Kanemoto H, et al. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Pancreas 2011; 40: 974-8. [ Links ]

    5. Zedan H, Hareadei AA, Abd-Elsayed AA, Abdel-Maguid EM. Cigarette smoking, hypertension and diabetes mellitus as risk factors for erectile dysfunction in upper Egypt. East Mediterr Health J 2010; 16: 281-5. [ Links ]

    6. Cho NH, Chan JC, Jang HC, Lim S, Kim HL, Choi SH. Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf) 2009; 71: 679-85. [ Links ]

    7. Fagard RH, Nilsson PM. Smoking and diabetes-the double health hazard! Prim Care Diabetes 2009; 3: 205-9. [ Links ]

    8. Currie LJ, Sharpe JR, Martin R. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg 2001; 108: 1713-26. [ Links ]

    9. Heistein JB, Cook PA. Factors affecting composite graft survival in digital tip amputations. Ann Plast Surg 2003; 50: 299-303. [ Links ]

    10. Mowlavi A, Andrews K, Milner S, Herndon DN, Heggers JP. The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg 2000; 45: 629-32. [ Links ]

    11. Ramos G, Guastavino MP, Bolgiani A, Prezzavento G. Patiño 0, Benaim F. Hypoalbuminemia in burned patients: an outcome marker that could define evolution periods. Revist Argent Quemad 2000; 15: 23-9. [ Links ]

    12. Vibe P, Pless J. A new method of skin graft adhesion. Scand J Plast Reconstr Surg 1983; 17: 263-4. [ Links ]

    1. Pernot F. La ruta de la seda. Londres: Parragon, 2001. [ Links ]

    2. Hyde N. Silk, the queen of textiles. National Geographic Magazine 1984; 65: 2-49. [ Links ]

    3. Wang X, Zhang X, Castellot J, Herman I, Iafrati M, Kaplan DL. Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials 2008; 29: 894-903. [ Links ]

    4. Zhang J, Pritchard E, Hu X, et al. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci U S A 2012; 109: 11981-6. [ Links ]

    5. Larrán de Vere A. Franklin. Biblioteca Billiken, Buenos Aires Editorial Atlántida, 1945. [ Links ]

    1. De Costa C. St Anthony´s fire and living ligatures: a short history of ergotamine. Lancet 2002; 359: 1768-70. [ Links ]

    2. Ruano Calderón L, Zermeño Pohls F. Ergotismo. Presentación de un caso y revisión de la bibliografía. Revista de Neurología 2005; 40: 412-6. [ Links ]

    3. Baldwin Z, Ceraldi C. Ergotism associated with HIV antiviral protease inhibitor therapy. J Vasc Surg 2003; 37: 676-8. [ Links ]

    4. Rosenthal E, Sala F, Chichmanian R, et al. Ergotism related to concurrent administration of ergotamine tartrate and indinavir. JAMA 1999; 281: 987. [ Links ]

    5. Mortier E, Pouchot J, Vinceneux P, Lalande M. Ergotism related to interaction between nelfinavir and ergotamine. Am J Med 2001; 110: 594. [ Links ]

    6. Montero A, Giovannoni A, Tvrde, P. Leg ischemia in a patient receiving ritonavir and ergotamine. Ann Intern Med 1999; 130: 329. [ Links ]

    7. Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D. Ergotism related to a single dose of ergotamine tartrato in an AIDS patient treated with ritonavir. Postgrad Med J 1999; 75: 546-8. [ Links ]

    8. Pardo Rey C, Yebra M, Borrallo M, Vega A, Ramos A, Montero M. Irreversible coma, ergotamine and ritonavir. Clin Infect Dis 2003; 37: 72-3. [ Links ]

    9. Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W. Cerebral ergotism under treatment with ergotamine and ritonavir. Neurology 2001; 57: 743. [ Links ]

    10. Frhlich G, Kaplan V, Amann-Vesti B. Holy fire in an HIV-positive man: a case of 21st-century Ergotism. CMAJ 2010; 182: 378-80. [ Links ]

    11. Vila A, Mykietiuk A, Bonvehí P, Temporiti A, Urueña A, Herrera F. Clinical ergotism induced by ritonavir. Scand J Infect Dis 2001; 33: 788-9. [ Links ]

    12. Caballero-Granado F, Viciana P, Cordero E, Gómez-Vera M, de Nozal M, López-Cortez L. Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient. Antimicrob Agents Chemother 1997; 45: 1207. [ Links ]

    13. Liaudet L, Buclin T, Jaccard C, Eckert P. Severe ergotism associated with interaction between ritonavir and ergotamine. BMJ 1999; 318: 771. [ Links ]

    14. Antopolsky M, Hiller N, Salameh S, Goldshtein B, Stalnikowicz R. Splenic infarction: 10 years of experience. Am J Emerg Med 2009; 27: 262-5. [ Links ]

    15. Yaacov R, Pokroy R, Berlowitz D, Aharoni D, Hain D, Breuer G. Splenic infarction: an update on William Osler´s observations. Isr Med Assoc J 2010; 12: 362-5. [ Links ]

    1. Faivre L, Collod-Beroud G, Loeys L, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007; 81: 454-66. [ Links ]

    2. Bolineau C, Jondeau G, Mizuguchi T, et al. Molecular genetics of Marfan syndrome. Curr Opin Cardiol 2005; 20: 194-200. [ Links ]

    3. Neptune E, Frinchmeyer PA, Arking DE, et al. Dysregulation of TFG-Beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003; 33: 407-11. [ Links ]

    4. den Heijer M, Lewintong S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3: 292-9. [ Links ]

    5. Giusti B, Porciani M, Brunelli T, et al. Phenotypic variability of cardiovascular manifestations in Marfan syndrome, possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. European Heart Journal 2003; 24: 2038-45. [ Links ]

    6. Loeys B, Dietz H, Braverman A, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-85. [ Links ]

    7. Hiroshi Matsuo: Clinical significance and impact of "painless acute aortic dissection". Official Journal of the Japanese Circulation Society 2011; 75: 47-8. [ Links ]

    8. Jeremy, RW, Huang H, Hwa J, et al. Relation between age, arterial distensibility and aortic dilatation in the Marfan syndrome. Am J cardiol 1994; 74: 369-73. [ Links ]

    9. Stanger O, Herman W, Pietrzik K, et al. Clinical use rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol 2004; 93: 439-53. [ Links ]

    10. Zittan E, Preis M, Asmir I, et al. High frequency of vitamin B12 deficiency in asymptomatic individuals homocygous to MTHFR C677T mutation is associated whit endothelial dysfunction and homocysteinemia. Am J Physiol Heart Circ Physiol 2007; 293: 860-5. [ Links ]

    1. Rabagliati R, Fuentes LG, Guzmán AM, et al. Enfermedad fúngica invasora en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la perspectiva de los criterios diagnósticos EORTC/MSG. Rev Chilena Infectol 2009; 26: 212-9. [ Links ]

    2. Pagano L, Caira M, Candoni A, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 2010; 95: 644-50. [ Links ]

    3. Barnes PD, Marr KA. Aspergillosis: spectrum of disease, diagnosis, and treatment. Infect Dis Clin North Am 2006; 20: 545-61. [ Links ]

    4. Galimberti R, Kowalczuk A, Hidalgo Parra I, Gonzalez Ramos G, Flores V. Cutaneous aspergillosis: a report of six cases. Br J Dermatol 1998; 139: 522-6. [ Links ]

    5. Nakashima K, Yamada N, Yoshida Y, Yamamoto O. Primary cutaneous aspergillosis. Acta Derm Venereol 2010; 90: 519-20. [ Links ]

    6. Nucci M, Anaissie E. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation: focus on aspergillosis. Clin Chest Med 2009; 30: 295-306. [ Links ]

    7. Martinez R, Castro G, Machado AA, Moya MJ. Primary aspergilloma and subacute invasive aspergillosis in two AIDS patients. Rev Inst Med Trop Sao Paulo 2009; 51: 49-52. [ Links ]

    8. Zhang QQ, Li L, Zhu M, Zhang CY, Wang JJ. Primary cutaneous aspergillosis due to Aspergillus flavus: a case report. Chin Med J 2005; 118: 255-7. [ Links ]

    9. Yuanjie Z, Jingxia D, Hai W, Jianghan C, Julin G. Primary cutaneous aspergillosis in a patient with cutaneous T-cell lymphoma. Mycoses 2008; 52: 462-4. [ Links ]

    10. Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: A 34-year experience. Clin Infect Dis 1999; 29: 1210-9. [ Links ]

    11. Grossman ME, Fithian EC, Behrens C, Bissinger J, Fracaro M, Neu HC. Primay cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol 1985; 12: 313-8. [ Links ]

    12. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171-8. [ Links ]

    13. Wheat LJ. Approach to the diagnosis of invasive aspergillosis and candidiasis. Clin Chest Med 2009; 30: 367-77. [ Links ]

    14. Tunccan G, Aki SZ, Akyrek N, Sucak G, Senol E. Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation. J Infect Dev Ctries 2011; 5: 406-9. [ Links ]

    1. Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512-9. [ Links ]

    2. Gross PA, Barrett TL, Dellinger P, et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis 1994; 18: 4. [ Links ]

    3. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report 2008; 8: 1-29. [ Links ]

    4. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002; 35: 113-25. [ Links ]

    5. Villar H, Jugo M, Santana G, Baserni M, Reil J. Aumento en la prevalencia de Streptococcus beta hemolíticos en hisopados faríngeos en Buenos Aires. Medicina (B Aires) 2005; 65: 311-4. [ Links ]

    6. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med 2001; 134: 506-8. [ Links ]

    7. Alcaide ML, Bisno AL. Pharyngitis and epiglottitis. Infect Dis Clin North Am 2007; 21: 449-69. [ Links ]

    8. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134: 509-17. [ Links ]

    9. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 2004; 291: 1587-95. [ Links ]

    10. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981; 1: 239-46. [ Links ]

    11. Halfon ST, Davies AM, Kaplan O, Lazarov E, Bergner- Rabinowitz S. Primary prevention of rheumatic fever in Jerusalem schoolchildren. 2. Identification of beta-hemolytic streptococci. Isr J Med Sci 1968; 4: 809-14. [ Links ]

    12. Bisno AL. Diagnosing strep throat in the adult patient: do clinical criteria really suffice? Ann Intern Med 2003; 139: 150-1. [ Links ]

    13. Gieseker KE, Mackenzie T, Roe MH, Todd JK. Comparison of two rapid Streptococcus pyogenes diagnostic tests with a rigorous culture standard. Pediatr Infect Dis J 2002; 21: 922-7. [ Links ]

    14. Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev 2004; 17: 571-80. [ Links ]

    15. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985; 253: 1271-4. [ Links ]

    16. Del Mar C, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev 2006; CD000023. [ Links ]

    17. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005; 5: 11. [ Links ]

    18. Regoli M, Chiappini E, Bonsignori F, Galli L, de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr 2011; 37: 10. [ Links ]

    19. Thomas M, Del Mar C, Glasziou P. How effective are treatments other than antibiotics for acute sore throat? Br J Gen Pract 2000; 50: 817-20. [ Links ]

    20. Korb K, Scherer M, Chenot JF. Steroids as adjuvant therapy for acute pharyngitis in ambulatory patients: a systematic review. Ann Fam Med 2010; 8: 58-63. [ Links ]

    21. Hayward G, Thompson M, Heneghan C, Perera R, Del Mar C, Glasziou P. Corticosteroids for pain relief in sore throat: systematic review and meta-analysis. BMJ 2009; 339: b2976. [ Links ]

    22. Schutz A, Gund HJ, Pschorn U, et al. Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept. Arzneimittelforschung 2002; 52: 194-9. [ Links ]

    23. Fischer J, Pschorn U, Vix JM, et al. Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties. Arzneimittelforschung 2002; 52: 256-63. [ Links ]

    24. Wessels MR. Clinical practice. Streptococcal pharyngitis. N Engl J Med 2011; 364: 648-55. [ Links ]

    25. Feder HM Jr, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 1999; 103: 47-51. [ Links ]

    26. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ 1993; 306: 1170-2. [ Links ]

    27. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119: 1541-51. [ Links ]

    28. Pichichero ME. Treatment and prevention of streptococcal tonsillopharyngitis. In: UpToDate, Dexton DJ, Edwards MS (Ed), UpToDate 2010. [ Links ]

    29. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98: 326. [ Links ]

    30. Tanz RR, Shulman ST. Streptococcal pharyngitis: the carrier state, definition, and management. Pediatr Ann 1998; 27: 281-5. [ Links ]

    31. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006; 55: 1-94. [ Links ]

    32. García S, Casco R, Perazzi B, De Mier C, Vay C, Famiglietti A. Resistencia de Neisseria gonorrhoeae a ciprofloxacina según hábitos sexuales. Medicina (B Aires) 2008; 68: 358-62. [ Links ]

    33. American Academy of Pediatrics, Subcommittee on Management of Acute Otitis Media. Diagnosis and Management of Acute Otitis Media. Pediatrics 2004; 113: 1451-65. [ Links ]

    34. Lous J, Burton MJ, Felding JU, Ovesen T, Rovers MM, Williamson I. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2005; CD001801. [ Links ]

    35. American Academy of Family Physicians; American Academy of Otolaryngology-Head and Neck Surgery; American Academy of Pediatrics Sub-committee on Otitis Media with Effusion. Otitis media with effusion. Pediatrics 2004; 113: 1412-29. [ Links ]

    36. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997; 99: 318-33. [ Links ]

    37. Gould JM, Matz PS. Otitis media. Pediatr Rev. 2010; 31: 102-16. [ Links ]

    38. López E, Vázquez M, Orlando N, et al. Streptococcus pneumoniae causing acute otitis media (aom): dynamic of serotype distribution in Buenos Aires, Argentina. Poster presentado en: 7th International Symposium on Pneumococci and Pneumococcal Diseases; 2010 March 14-18; Tel Aviv, Israel. [ Links ]

    39. Scottish Intercollegiate Guidelines Network. Diagnosis and management of childhood otitis media in primary care. February 2003 En: http://www.sign.ac.uk/pdf/sign66.pdf; consultado 26/11/2010. [ Links ]

    40. Coker TR, Chan L, Newberry S, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children. A Systematic Review. JAMA 2010; 304: 2161-9. [ Links ]

    41. Flynn CA, Griffin GH, Schultz JK. Descongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev 2004; CD001727. [ Links ]

    42. Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AW. National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J 2001; 20: 140-4. [ Links ]

    43. Bezáková N, Damoiseaux RA, Hoes AW, Schilder AG, Rovers MM. Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants BMJ 2009; 338: b 2525. [ Links ]

    44. National Institute for Health and Clinical Excellence. Prescribing of antibiotics for self limiting respiratory tract infections in adults and children in primary care. 2008 (Clinical guideline 69) En: www.nice.org.uk/CG69; consultado 26/11/2010 [ Links ]

    45. Sanders SL, Glasziou PP, Del Mar C, Rovers M. Antibiotics for acute otitis media in children (Review) Cochrane Database Syst Rev 2009; 1-43. [ Links ]

    46. Cates C, Dr Chris Cates' EBM Web Site. En: www.nntonline.net; consultado 11/03/2011 [ Links ]

    47. Fossati S, Gagetti P, Reijtman V, et al and the Sireva-II Working Group-Argentina. Serotype distribution, antibiotic resistance and coverage of pneumococcal conjug